Patent · US Active

Benzazole compounds and methods for making and using the compounds

US10065946B2 · kind B2 · utility

4Cited by
21References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2016
Grant dateSep 4, 2018
Priority date
Expiry dateAug 2, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are novel benzazole compounds and compositions comprising the compounds. The compounds are useful as kinase inhibitors including interleukin receptor associated kinases (IRAK) inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.